Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper‐relaxant responses to S‐nitrosoglutathione in a hyperoxic murine model

Bronchopulmonary dysplasia (BPD) with airway hyperreactivity is a long‐term pulmonary complication of prematurity. The endogenous nonadrenergic, noncholinergic signaling molecule, S‐nitrosoglutathione (GSNO) and its catabolism by GSNO reductase (GSNOR) modulate airway reactivity. Tracheomalacia is a major, underinvestigated complication of BPD. We studied trachealis, left main bronchus (LB), and intrapulmonary bronchiolar (IPB) relaxant responses to GSNO in a murine hyperoxic BPD model.

[1]  Richard J Martin,et al.  Early inspired oxygen and intermittent hypoxemic events in extremely premature infants are associated with asthma medication use at two years of age , 2018, Journal of Perinatology.

[2]  S. McGrath-Morrow,et al.  Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More , 2018, Annals of the American Thoracic Society.

[3]  R. Shinohara,et al.  Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia , 2017, Annals of the American Thoracic Society.

[4]  S. Berkelhamer,et al.  Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes , 2017, Journal of clinical medicine.

[5]  C. Bui,et al.  Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist. , 2016, American journal of respiratory cell and molecular biology.

[6]  Richard J Martin,et al.  S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia , 2016, Molecular Pharmacology.

[7]  L. Doyle,et al.  Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era , 2016, Thorax.

[8]  S. Jadcherla,et al.  Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions , 2016, PloS one.

[9]  H. Panitch,et al.  Paediatric Tracheomalacia. , 2016, Paediatric respiratory reviews.

[10]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[11]  Richard J Martin,et al.  Airway Hyperreactivity Is Delayed after Mild Neonatal Hyperoxic Exposure , 2015, Neonatology.

[12]  S. Kotecha,et al.  Effect of Bronchodilators on Forced Expiratory Volume in 1 s in Preterm-Born Participants Aged 5 and Over: A Systematic Review , 2015, Neonatology.

[13]  B. Gaston,et al.  Nitrogen chemistry and lung physiology. , 2015, Annual review of physiology.

[14]  W. Busse,et al.  Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity , 2014, European Respiratory Journal.

[15]  V. Bhandari,et al.  Animal models of bronchopulmonary dysplasia. The term mouse models. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[16]  Richard J Martin,et al.  Repeated β2-Adrenergic Receptor Agonist Therapy Attenuates the Response to Rescue Bronchodilation in a Hyperoxic Newborn Mouse Model , 2014, Neonatology.

[17]  S. Mutka,et al.  Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation , 2014, BMC Pulmonary Medicine.

[18]  R. Harding,et al.  Altered Small Airways in Aged Mice following Neonatal Exposure to Hyperoxic Gas , 2013, Neonatology.

[19]  P. Vanhoutte.  Airway epithelium-derived relaxing factor: myth, reality, or naivety? , 2013, American journal of physiology. Cell physiology.

[20]  B. Undem,et al.  Autonomic neural control of intrathoracic airways. , 2012, Comprehensive Physiology.

[21]  B. Ryffel,et al.  Enhancement of Methacholine-Evoked Tracheal Contraction Induced by Bacterial Lipopolysaccharides Depends on Epithelium and Tumor Necrosis Factor , 2012, Journal of allergy.

[22]  G. Rosenthal,et al.  Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. , 2012, Biochemistry.

[23]  A. Ohlsson,et al.  Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. , 2012, The Cochrane database of systematic reviews.

[24]  L. Palmer,et al.  Gender Differences in S-Nitrosoglutathione Reductase Activity in the Lung , 2010, PloS one.

[25]  Neil Marlow,et al.  Lung Function and Respiratory Symptoms at 11 Years in Children Born Extremely Preterm: The Epicure Study , 2011, Pediatrics.

[26]  J. Stamler,et al.  GSNO reductase and β2-adrenergic receptor gene–gene interaction: bronchodilator responsiveness to albuterol , 2010, Pharmacogenetics and genomics.

[27]  J. Stamler,et al.  S-nitrosoglutathione reductase: an important regulator in human asthma. , 2009, American journal of respiratory and critical care medicine.

[28]  W. Gilbert,et al.  Cost, causes and rates of rehospitalization of preterm infants , 2007, Journal of Perinatology.

[29]  W. M. Foster,et al.  Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. , 2007, American journal of respiratory and critical care medicine.

[30]  Matthew W. Foster,et al.  Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2 , 2007, Cell.

[31]  Limin Liu,et al.  Protection from Experimental Asthma by an Endogenous Bronchodilator , 2005, Science.

[32]  R. Ehrenkranz,et al.  Statement on the care of the child with chronic lung disease of infancy and childhood. , 2003, American journal of respiratory and critical care medicine.

[33]  A. Tanswell,et al.  Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat. , 2003, Journal of applied physiology.

[34]  R. Marthan,et al.  Pharmacologically induced relaxation of tracheal smooth muscle is increased in hyperoxia‐exposed 15‐day‐old rats , 2002, Pediatric pulmonology.

[35]  P. Huang,et al.  Regulation of murine airway responsiveness by endothelial nitric oxide synthase. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[36]  J. Stamler,et al.  Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure , 1998, The Lancet.

[37]  R. Johns,et al.  Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  J. Stamler,et al.  Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. , 1994, The Journal of pharmacology and experimental therapeutics.

[39]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[41]  J. Stamler,et al.  Modulation of vasoactive intestinal peptide pulmonary relaxation by NO in tracheally superfused guinea pig lungs. , 1993, The American journal of physiology.

[42]  A. Greenough,et al.  Variable response to bronchodilator therapy in young children born prematurely. , 1993, Respiratory medicine.

[43]  R. Guthrie,et al.  Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. , 1987, The American review of respiratory disease.